Serums Clinical Trial

MMBalance™, MMRepose™, MMRevive™

The purpose of this IRB approved biomedical research study was to determine and measure benefits from 13 subjects with twice daily use of MMSkincare™ serums over a 12-week period. The serums include MMBalance™ to treat acne-prone skin, MMRepose™ to treat rhytides (fine lines) and dull skin, and MMRevive™ to treat UV damage, hyperpigmentation, rosacea, and inflamed skin. Results were measured at 4 weeks and at 12 weeks via qualitative as well as quantitative data using photographic artificial intelligence analysis.

MMBALANCE SUBJECTS

62%

MMBalance Subjects:
After 30 days of regular use, 62% of subjects saw an improvement in acne

BEFORE / AFTERS


MMREPOSE SUBJECTS

92%

After 30 days of regular use, 92% of participants saw an improvement in overall complexion and skin texture.

53%

53.3% of subjects reported a decrease in rhytides (fine lines) from baseline to week 12.

BEFORE / AFTERS

MMREVIVE SUBJECTS

42%

After 30 days of regular use, 42% of subjects reported an improvement in epidermal inflammation

46%

After 30 days of regular use, 46% of subjects reported an improvement in skin sensitivity

62%

62.7% of subjects reported a decrease in skin dyspigmentation from baseline to week 12

BEFORE / AFTERS